NCT04342195View on ClinicalTrials.gov

Acquiring Convalescent Specimens for COVID-19 Antibodies

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

March 25, 2020

Primary Completion Date

March 12, 2021

Study Completion Date

March 12, 2021

Conditions
COVID-19Coronavirus InfectionCorona Virus Infection
Interventions
PROCEDURE

Blood draw

Participants will have approximately 45 ml of whole blood drawn (3 Tablespoons) drawn at the study visit.

Trial Locations (1)

10032

Columbia University Irving Medical Center/NYP, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT04342195 - Acquiring Convalescent Specimens for COVID-19 Antibodies | Biotech Hunter | Biotech Hunter